FATE THERAPEUTICS INC·4

Jan 13, 4:02 PM ET

Valamehr Bahram 4

4 · FATE THERAPEUTICS INC · Filed Jan 13, 2023

Insider Transaction Report

Form 4
Period: 2023-01-12
Valamehr Bahram
DirectorPresident and CEO
Transactions
  • Exercise/Conversion

    Common Stock

    2023-01-12$1.37/sh+423$580169,340 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2023-01-12+4230 total
    Exercise: $1.37Exp: 2023-01-14Common Stock (423 underlying)
Footnotes (1)
  • [F1]This option is fully vested.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION